Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic paracetamol with Synflorix + Infanrix hexa + Rotarix in infants
2006-000559-16Phase 3Completed
- Sponsor
- GSK
- Start
- May 2006
- Modality
- Small Molecules, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of acetaminophen, 10-valent pneumococcal conjugate vaccine, pertussis filamentous haemagglutinin and human rotavirus RIX4414 strain vaccine in pneumococcal disease, diphtheria, Tetanus and 5 more (2 arms), sponsored by GSK. Primary endpoint: Reduction in febrile reactions. Started May 2006; status: completed.
02
Drugs
acetaminophen10-valent pneumococcal conjugate vaccinepertussis filamentous haemagglutininhuman rotavirus RIX4414 strain vaccine
03
Conditions
pneumococcal diseasediphtheriaTetanuspertussishepatitis B (HBV)
Beyond the preview
Go deeper on 2006-000559-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000559-16.